Oregon Health & Science University
Dermatology residency · Portland, OR · Program website
- 2
- Faculty
- 15
- Trainees
- 86
- Papers
- 53%
- Trainees published
- 33%
- First author
2 people are awaiting a match decision, so numbers may change.
Papers
By this program's faculty and trainees since 2022, 86 in all. Updated 2026-11-07.
- Diagnostic Value of Skin Biopsy in Fatal Histoplasmosis-Associated Hemophagocytic Lymphohistiocytosis: A Case ReportJaclyn Roland-McGowan et al. · Dermatology and Therapy · 2026 · PubMed
- Adult-onset Still’s disease: Sequential atypical rashes—Persistent plaques and flagellate erythemaKatelyn Downey et al. · JAAD Case Reports · 2026 · PubMed
- 0350 Risk of skin and subcutaneous diseases in pediatric HIV-exposed uninfected individuals in the United StatesGhida El-Banna et al. · Journal of Investigative Dermatology · 2026
- 0325 The child eczema control tool: Preliminary results from an ongoing psychometric validation studyJ. Gillespie et al. · Journal of Investigative Dermatology · 2026
- Perianal squamous cell carcinoma in the absence of HPV or immunosuppression: A rare case reportVincent Doan et al. · JAAD Case Reports · 2026 · PubMed
- Initial psychometric validation of the Caregiver Atopic Dermatitis Control ToolMilie M. Fang et al. · Clinical and Experimental Dermatology · 2026 · PubMed
- 76509 Medical Management of Fibrosing Disorders with Energy-Based Devices: A Literature ReviewNicholas Chin et al. · Journal of the American Academy of Dermatology · 2026
- 77172 Quality of Life in Vegetative Pyoderma GangrenosumRichard Zhang et al. · Journal of the American Academy of Dermatology · 2026
- 71084 Psychometric Validation of The Caregiver and Child Atopic Dermatitis Control Tools: A Preliminary AnalysisJordan A. Gillespie et al. · Journal of the American Academy of Dermatology · 2026
- Emerging topical nonsteroidal therapies in pediatric dermatology: atopic dermatitis, psoriasis, alopecia areata, vitiligo, and seborrheic dermatitisJordan A. Gillespie et al. · Current Opinion in Pediatrics · 2026 · PubMed
How trainees publishauthor positions, faculty co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 8 of 15 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Jesse Keller, M.D., M.C.R. | Autoimmune and Inflammatory Disorders; Psychosomatic Disorders and Their Treatments | 15 | 22 | 2 | 13 | 0.35 |
| Julie Dhossche, M.D. | Dermatology and Skin Diseases; Cancer and Skin Lesions | 6 | 20 | 1 | 9 | 0.58 |
15 trainees are counted above but never listed by name.
About Oregon Health & Science Universityinstitution-wide dermatology research
Dermatology publications from Oregon Health & Science University and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
Works per year · * 2026 so far
Dermatology research topics at Oregon Health & Science University
Papers in the window; each links to the list on OpenAlex.
Most cited at Oregon Health & Science University since 2024
All dermatology papers there on OpenAlex
- Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trialsJonathan I. Silverberg et al. · Journal of the American Academy of Dermatology · 2024 · PubMed · cited 111
- Stigmatization and Mental Health Impact of Chronic Pediatric Skin DisordersAmy S. Paller et al. · JAMA Dermatology · 2024 · PubMed · cited 80
- Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and ChildrenEric Lawrence Simpson et al. · JAMA Dermatology · 2024 · PubMed · cited 71
- Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension StudyAmy S. Paller et al. · American Journal of Clinical Dermatology · 2024 · PubMed · cited 69
- Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK InhibitorsRichard W. Kim et al. · American Journal of Clinical Dermatology · 2024 · PubMed · cited 64
- Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of ExposureEric Lawrence Simpson et al. · American Journal of Clinical Dermatology · 2024 · PubMed · cited 57
- A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema CouncilCarter K. Haag et al. · British Journal of Dermatology · 2024 · PubMed · cited 55
- Endotypes, phenotypes, and biomarkers in chronic spontaneous urticariaDavid Michael Lang et al. · Annals of Allergy Asthma & Immunology · 2024 · PubMed · cited 51
- Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trialEric Lawrence Simpson et al. · Journal of the American Academy of Dermatology · 2024 · PubMed · cited 51
- Focused update: Guidelines of care for the management of atopic dermatitis in adultsDawn Marie R. Davis et al. · Journal of the American Academy of Dermatology · 2025 · PubMed · cited 43